{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T09:57:24Z","timestamp":1696586244178},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T00:00:00Z","timestamp":1318550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Recently, low\u2010dose transdermal buprenorphine (<jats:styled-content style=\"fixed-case\">LD\u2010TD\u2010BUP<\/jats:styled-content>) was introduced for treatment of patients with chronic non\u2010malignant pain. The primary aim of this study was to determine the proportion of patients who were prescribed <jats:styled-content style=\"fixed-case\">LD\u2010TD\u2010BUP<\/jats:styled-content> for non\u2010malignant pain who became long\u2010term users. The secondary aim was to determine the proportion of patients who co\u2010medicated with other opioids or benzodiazepines during treatment with <jats:styled-content style=\"fixed-case\">LD\u2010TD\u2010BUP<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Data were drawn from the <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>orwegian <jats:styled-content style=\"fixed-case\">P<\/jats:styled-content>rescription <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>atabase that covers all prescriptions dispensed at pharmacies to the entire <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>orwegian population (4.7\u2009million inhabitants). The study population consisted of all patients who were dispensed at least one prescription of <jats:styled-content style=\"fixed-case\">LD\u2010TD\u2010BUP<\/jats:styled-content> from its introduction in <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>ovember 2005 to 31 <jats:styled-content style=\"fixed-case\">D<\/jats:styled-content>ecember 2008. Patients who were dispensed more than 24 patches (\u2265\u20096\u2009months) were defined as long\u2010term users. Reimbursement codes were used to stratify patients as having cancer pain or non\u2010malignant pain.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among new users of <jats:styled-content style=\"fixed-case\">LD\u2010TD\u2010BUP<\/jats:styled-content> for non\u2010malignant pain (<jats:italic>n<\/jats:italic>\u2009=\u200913,451), only 22% became long\u2010term users, while 44% were only dispensed one prescription. Among long\u2010term users who were opioid naive when <jats:styled-content style=\"fixed-case\">LD\u2010TD\u2010BUP<\/jats:styled-content> was initiated, 43% co\u2010medicated with other opioids or benzodiazepines, compared with 82% of those who previously had used opioids.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Three years after introduction, 0.4% of the <jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>orwegian population had been dispensed <jats:styled-content style=\"fixed-case\">LD\u2010TD\u2010BUP<\/jats:styled-content>. Only one\u2010fifth had become long\u2010term users. Those who used opioids before the first dispension of <jats:styled-content style=\"fixed-case\">LD\u2010TD\u2010BUP<\/jats:styled-content> co\u2010medicated with other potentially addictive drugs to a much higher degree compared with those who were opioid naive.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1399-6576.2011.02537.x","type":"journal-article","created":{"date-parts":[[2011,10,14]],"date-time":"2011-10-14T14:49:39Z","timestamp":1318603779000},"page":"88-94","source":"Crossref","is-referenced-by-count":6,"title":["Low\u2010dose transdermal buprenorphine \u2013 long\u2010term use and co\u2010medication with other potentially addictive drugs"],"prefix":"10.1111","volume":"56","author":[{"given":"A.","family":"NORDB\u00d8","sequence":"first","affiliation":[{"name":"Department of Palliative Medicine Division of Oncology Oslo University Hospital  Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"SKURTVEIT","sequence":"additional","affiliation":[{"name":"Department of Pharmacoepidemiology Division of Epidemiology The Norwegian Institute of Public Health  Oslo Norway"},{"name":"Norwegian Centre for Addiction Research Faculty of Medicine University of Oslo  Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. C.","family":"BORCHGREVINK","sequence":"additional","affiliation":[{"name":"Pain and Palliation Research Group Faculty of Medicine Norwegian University of Science and Technology  Trondheim Norway"},{"name":"National Competence Centre for Complex Symptom Disorders St. Olav University Hospital  Trondheim Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"KAASA","sequence":"additional","affiliation":[{"name":"Pain and Palliation Research Group Faculty of Medicine Norwegian University of Science and Technology  Trondheim Norway"},{"name":"Department of Oncology St. Olav University Hospital  Trondheim Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. M.","family":"FREDHEIM","sequence":"additional","affiliation":[{"name":"Pain and Palliation Research Group Faculty of Medicine Norwegian University of Science and Technology  Trondheim Norway"},{"name":"National Competence Centre for Complex Symptom Disorders St. Olav University Hospital  Trondheim Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,10,14]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/eujp.2001.0241"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2006.06.009"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2008.10.008"},{"key":"e_1_2_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1090-3801(02)00143-X"},{"key":"e_1_2_5_6_1","volume-title":"Treatment recommendation: use of opioid in chronic non\u2010malignant pain \u2013 an update","author":"Norwegian Medicines Agency","year":"2008"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2010.04.006"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjpain.2010.05.035"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2010.04.018"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/216725"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2010.01.013"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.10.010"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.03.001"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.08.022"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2008.11.005"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2009.00494.x"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpain.2009.05.006"},{"key":"e_1_2_5_18_1","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.ATC classification index with DDDs. Oslo;2009. Available from:http:\/\/www.whocc.no"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.09.019"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006605.pub2"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2007.03.028"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.2006.01154.x"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.2011.02537.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.2011.02537.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:48:30Z","timestamp":1695509310000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.2011.02537.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,14]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.1111\/j.1399-6576.2011.02537.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.2011.02537.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,14]]}}}